T Lymphocyte Potential Marks the Emergence of Definitive Hematopoietic Progenitors in Human Pluripotent Stem Cell Differentiation Cultures
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
The efficient generation of hematopoietic stem cells from human pluripotent stem cells is dependent on the appropriate specification of the definitive hematopoietic program during differentiation. In this study, we used T lymphocyte potential to track the onset of definitive hematopoiesis from human embryonic and induced pluripotent stem cells differentiated with specific morphogens in serum- and stromal-free cultures. We show that this program develops from a progenitor population with characteristics of hemogenic endothelium, including the expression of CD34, VE-cadherin, GATA2, LMO2, and RUNX1. Along with T cells, these progenitors display the capacity to generate myeloid and erythroid cells. Manipulation of Activin/Nodal signaling during early stages of differentiation revealed that development of the definitive hematopoietic progenitor population is not dependent on this pathway, distinguishing it from primitive hematopoiesis. Collectively, these findings demonstrate that it is possible to generate T lymphoid progenitors from pluripotent stem cells and that this lineage develops from a population whose emergence marks the onset of human definitive hematopoiesis.
Li M, Suzuki K, Wang M, Benner C, Ku M, Ma L Sci China Life Sci. 2025; .
PMID: 40080269 DOI: 10.1007/s11427-024-2816-0.
Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells.
Lindenbergh P, van der Stegen S Transfus Med Hemother. 2025; 52(1):27-41.
PMID: 39944411 PMC: 11813279. DOI: 10.1159/000540473.
In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs).
Chukwuemeka C, Ndubueze C, Kolawole A, Joseph J, Oladipo I, Ofoezie E Blood Sci. 2024; 7(1):e00215.
PMID: 39726795 PMC: 11671056. DOI: 10.1097/BS9.0000000000000215.
Decoding the human prenatal immune system with single-cell multi-omics.
Haniffa M, Maartens A, Winheim E, Jardine L Nat Rev Immunol. 2024; .
PMID: 39482372 DOI: 10.1038/s41577-024-01099-1.
Generation of autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy.
Maneechai K, Khopanlert W, Noiperm P, Udomsak P, Viboonjuntra P, Julamanee J Heliyon. 2024; 10(19):e38447.
PMID: 39398019 PMC: 11467635. DOI: 10.1016/j.heliyon.2024.e38447.